CCDC80 and metabolic dysfunction-associated steatotic liver disease: To further explore the potential functional role of the key SBCs CCDC80 and SOD3 in NAFLD, we treated liver HepG2 cells separately with CCDC80 and SOD3 recombinant protein for 24 h.